Sars cov 2 Antigen Rapid Test Kit

sars cov 2 an infection
sars cov 2 an infection

Abstract

Background

The Coronavirus sickness 2019 (COVID-19) pandemic continues to unfold internationally. Ensuing from this actuality, there’s an urgent need for fast, easy, and proper assessments to diagnose excessive acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an an an an infection. Effectivity traits of the speedy SARS-CoV-2 antigen detection check out needs to be evaluated and in distinction with the gold customary real-time reverse transcription-polymerase chain response (RT-PCR) check out for prognosis of COVID-19 circumstances

Effectivity Traits

JOYSBIO’s coronavirus Ag check out gear was independently evaluated at Centro Diagnostico Delta S.r.l. in Italy between October 2020 and January 2021. A complete of 107 constructive specimens had been examined with JOYSBIO’s COVID-19 Antigen Speedy Affirm Devices. These specimens had been collected from victims who’re suspected of COVID-19 with nasal swabs. The coronavirus antigen check out gear’s sensitivity and specificity are in distinction inside the course of a CE-IVD marked RT-PCR check out gear. This medical evaluation is carried out beneath the thought SARS-CoV merely just isn’t spreading domestically. 

Primarily based completely on the medical analysis of 492 samples, the detection sensitivity is 98.13%, and the specificity is 99.22%.

  • Constructive % Settlement (PPA) = 105/107 (98.13%) (95%CI: 93.4%~99.8%)
  • Adversarial % Settlement (NPA) = 382/385 (99.22%) (95%CI:97.7%~99.8%)
  • Accuracy = (105+382)/492×100%=98.98%
  • Kappa = 2×(105×382-3×2)/(108×385+107 ×384) = 0.97>0.5

The prohibit of detection (LOD) of this product is 1.6 x 102 TCID50/mL, calculated by the use of a gradient dilution methodology.

sars cov 2
sars cov 2

Please Observe:

 Beneath listed kits are validated with the talked about batch amount solely. Obligation for batch to batch consistency would not lies with ICMR.
 Minimal acceptance requirements of sensitivity and specificity of Speedy Ag Affirm Kits:
 Validated as a Stage of Care Affirm (POCT) with out transport to a laboratory setupSensitivity: 50% and above; Specificity: 95% and above
 Validated in a laboratory setup with samples collected in Viral Transport Medium (VTM)- Sensitivity: 70% and above; Specificity: 99% and above
 Antigen based totally fully speedy assessments which could possibly be US-FDA permitted will doubtless be utilized instantly after due promoting and selling approval from DCGI.

In June 2020, JOYSBIO Biotechnology proudly launched a model new COVID-19 Antigen Speedy Affirm Devices (Colloidal Gold). The model new coronavirus antigen check out gear is a lateral change immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) in greater respiratory samples with nasal swabs or saliva inside the midst of the acute part of an an an an infection. An uncut sheet format is accessible in the marketplace.

sars cov 2 infection
sars cov 2 an infection

Choices

  • 15-minute speedy detection
  • Simple-to-operate coronavirus antigen check out
  • Tons less-invasive nasal (NS) swab sample assortment
  • CE-IVD marked
  • Accessible in half/5/20 assessments/subject.

COVID-19 Antigen Affirm Course of

  1. Twist off the cap of the buffer bottle, fastidiously dispense all buffer into the extraction tube。 
  2. After accumulating greater respiratory sample with nasal swab, insert the swab into the extraction tube, plunge the swab up and down all by way of the fluid for at the least 10 seconds. Maintain the swab inside the course of the underside of the tube, rotate three turns. DO NOT splash liquid out of the tube. 
  3. Take away the swab whereas squeezing the sides of the tube to extract the liquid from the swab. 
  4. Press the nozzle cap firmly onto the extraction tube. Mix completely by swirling or flicking the underside of the tube. 
  5. Gently squeeze the tube’s rigid physique, dispense two (2) drops of the buffer-specimen mixture into the sample accurately on the coronavirus antigen check out cassette.
  6. Look at the check out outcomes between 15 and 20 minutes. Do not be taught the outcomes after 20 minutes.

Key Components

  • This interim steering is supposed for healthcare suppliers who order antigen assessments, buy antigen check out outcomes, or perform point-of-care testing, along with for laboratory professionals who perform antigen testing in a laboratory setting or on the extent of care and report these outcomes.
  • The purpose of this interim technical steering is to assist setting nice medical and public accurately being use of antigen assessments for fairly a number of testing circumstances.
  • This steering applies to all medical and shopper makes use of of antigen assessments and is not explicit to any express age group.

Methods

The speedy SARS-CoV-2 antigen detection check out, Customary Q COVID-19 Ag gear (SD Biosensor®, Republic of Korea), was in distinction with the real-time RT-PCR check out, Allplex 2019-nCoV Assay (Seegene®, Korea) for detection of SARS-CoV-2 in respiratory specimens. Four hundred fifty-four respiratory samples (primarily nasopharyngeal and throat swabs) had been obtained from COVID-19 suspected circumstances and converse to of us, along with pre-operative victims at Siriraj Hospital, Bangkok, Thailand all by the use of March–Could 2020.

Outcomes

Of 454 respiratory samples, 60 (13.2%) had been constructive, and 394 (86.8%) had been detrimental for SARS-CoV-2 RNA by real-time RT-PCR assay. The dimensions from onset to laboratory check out in COVID-19 suspected circumstances and converse to of us ranged from Zero to 14 days with a median of three days. The speedy SARS-CoV-2 antigen detection check out’s sensitivity and specificity had been 98.33% (95% CI, 91.06–99.96%) and 98.73% (95% CI, 97.06–99.59%), respectively. One false detrimental check out consequence was from a sample with a extreme real-time RT-PCR cycle threshold (Ct), whereas 5 false constructive check out outcomes had been from specimens of pre-operative victims.

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 94
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold)

abx092015-40tests 40 tests
EUR 432

Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold)

abx092016-40tests 40 tests
EUR 432

Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold)

abx092049-20tests 20 tests
EUR 230

Melamine (MEL) Rapid Test Kit

abx092057-50tests 50 tests
EUR 370

Clenbuterol (CLE) Rapid Test Kit

abx092058-50tests 50 tests
EUR 244

Ractopamine (RAC) Rapid Test Kit

abx092059-50tests 50 tests
EUR 244

Salbutamol (SAL) Rapid Test Kit

abx092060-50tests 50 tests
EUR 244

Tetracycline (TCs) Rapid Test Kit

abx092063-50tests 50 tests
EUR 398

Sulfonamides (Sas) Rapid Test Kit

abx092064-40tests 40 tests
EUR 398

Quinolones (QNs) Rapid Test Kit

abx092065-40tests 40 tests
EUR 398

Ciprofloxacin (CPFX) Rapid Test Kit

abx092066-50tests 50 tests
EUR 398

Quinolones (QNs) Rapid Test Kit

abx092067-40tests 40 tests
EUR 398

Brucella Antibody Rapid Test Kit

abx092069-40tests 40 tests
EUR 356

Rapid Leishmania Ab Test Kit

RB2104 1 box
EUR 127
Description: Please check the datasheet of Rapid Leishmania Ab Test Kit before using the test.

Rapid PED Ag Test Kit

RG14-01 1 box
EUR 159.9
Description: Please check the datasheet of Rapid PED Ag Test Kit before using the test.

IBD rapid test strip

RG15-04 10 boxes
EUR 148
Description: Please check the datasheet of IBD rapid test strip before using the test.

Rabies rapid test strip

RG18-01 10 boxes
EUR 151.92
Description: Please check the datasheet of Rabies rapid test strip before using the test.

SARS-CoV-2 Antigen Rapid Test Kit (Colloidal gold Immunoassay)

CoV2Ag-25 25 Tests/Kit
EUR 35
Description: This SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold) uses the sandwich immunocapture method and colloidal gold immunochromatography to qualitatively determine the presence of SARS-CoV-2 antigens in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

Avian Influenza H5 Virus Antigen Rapid Test Kit (Colloidal gold)

abx092014-40tests 40 tests
EUR 488

Avian Influenza H7 Virus Antigen Rapid Test Kit (Colloidal gold)

abx092017-40tests 40 tests
EUR 432

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)

IOV87952 20T/kit
EUR 39
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Clenbuterol Rapid Test Kit (Colloidal gold)

abx092040-50tests 50 tests
EUR 272

Ractopamine Rapid Test Kit (Colloidal gold)

abx092042-50tests 50 tests
EUR 300

Salbutamol Rapid Test Kit (Colloidal gold)

abx092043-50tests 50 tests
EUR 342

Chloramphenicol Rapid Test Kit (Colloidal gold)

abx092045-50tests 50 tests
EUR 356

LEAVE A REPLY

Please enter your comment!
Please enter your name here